This is where we started, focusing first on anti-aging and IV therapies, then quickly adopting emerging treatments to improve cognitive, physical, and sexual health
By targeting three complementary hormone receptors simultaneously, these investigational therapies aim to improve multiple aspects of metabolic health rather than focusing solely on glucose control
Obesity and Severe Prevalence in Adults: United States, August 2021-August 2023
UBT251 shows some promise, but remains too early, according to BMO
It is also important to note that most of these studies focus on short-term effects that may not hold up with extended use
Phase 3 trials test the candidate in larger populations and provide much of the evidence used in regulatory review